drugset / Trial / NCT02875288
Trial of Liposomal Versus Plain Bupivacaine in Minimally Invasive General Surgery Procedures
RandomizedParallel-groupSingle-blindTreatment
Summary
Aim: To compare the postoperative outcomes after surgical infiltration with plain bupivacaine compared to liposomal bupivacaine in patients undergoing elective, minimally invasive, general surgery procedures. To the investigators knowledge, there are no head-to-head, prospective, randomized, controlled trials of plain bupivacaine versus liposomal bupivacaine to evaluate postoperative pain and return of function.
Timeline
- Start
- 2015-12
- Primary completion
- 2020-01-06
- Completion
- 2020-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |
| Subject | Plain bupivacaine | Unknown | 0.25 % | Other |
| Subject | Plain bupivacaine | Unknown | 30 ml | Other |